Wednesday, June 26, 2024
9:18 AM EST – Bee Vectoring Technologies International : Announces an R&D agreement with Syensqo (2NF.F) (SYENS.BR) to develop its proprietary biological control agent Clonostachys rosea strain CR-7 into a seed treatment formulation for the multi-billion soybean market. “Collaborating with Syensqo is a huge extension of our R&D efforts,” said Ashish Malik, CEO of BVT. “Their large team of formulation chemists and microbiologists will enable us to get to market with a strong seed treatment formulation much faster.” Bee Vectoring Technologies International (C.BEE) shares were unchanged at 0.01.
Stocks in Play: Bee Vectoring Technologies International , Wed, 26 Jun 2024 09:27:06 EST